There have been no injuries or deaths associated with the recall.
“A reduced-energy electrical shock may fail to correct an irregular heartbeat or may cause an irregular heartbeat,” the FDA said in a news release. A software update is currently available, a Medtronic spokesperson told Becker’s.
The Minneapolis-based company recalled four products: Cobalt XT, Cobalt, and Crome Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
